Expertise in
2
conditions

Tessa L. Holyoake

21 Shelley Road, 
Glasgow, SCT, GB 
Expertise in
2
conditions
21 Shelley Road, 
Glasgow, SCT, GB 

Overview

Tessa Holyoake practices practicing medicine in Glasgow, United Kingdom.

Ms. Holyoake is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Philadelphia-Negative Chronic Myeloid Leukemia, and Retinoblastoma.

She is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

21 Shelley Road, Glasgow, SCT G120ZD, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2

72 Total Publications

Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.
Journal: Cancers
Published: June 30, 2022

Frequently Asked Questions about Tessa L. Holyoake

Is Tessa L. Holyoake a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Tessa L. Holyoake is classified as an Distinguished expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tessa L. Holyoake participate in research or clinical trials?

Yes. Tessa L. Holyoake has published 72 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Tessa L. Holyoake's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Holyoake's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile